ClinicalTrials.Veeva

Menu

RESTORE in Patients Who Had COVID-19 and Close Others

University Health Network, Toronto logo

University Health Network, Toronto

Status

Unknown

Conditions

Depressive Symptoms
PTSD
Anxiety
Mental Health

Treatments

Behavioral: RESTORE: Recovering from Extreme Stressors Through Online Resources and E-health

Study type

Interventional

Funder types

Other

Identifiers

NCT04958902
REB# 21-5394-0

Details and patient eligibility

About

There is considerable need for psychological intervention targeting stressor-related mental health symptoms related to COVID-19. The investigators have developed an online self-directed transdiagnostic intervention to address this need called RESTORE: Recovering from Extreme Stressors Through Online Resources and E-health. The specific aims of this project are to refine and investigate the initial safety, efficacy, and desirability of RESTORE for addressing mental-health symptoms in individuals who have recovered from severe COVID-19 and close others.

Full description

This uncontrolled pilot interventional study will examine the feasibility and preliminary efficacy of RESTORE. RESTORE is a guided self-directed online intervention to improve anxiety, depression, and posttraumatic stress disorder (PTSD) in individuals exposed to COVID-19 related traumatic or extreme stressors. RESTORE is based on evidence-based psychotherapies and has been designed to overcome many of the barriers associated with accessing evidence-based psychotherapies. The intervention will be iteratively refined over the course of the study. The guidance methods will also be refined over the course of the study

The primary hypotheses are that RESTORE will be safe, feasible, and desirable to participants, and will lead to improvements in mental health symptom severity from baseline to post-intervention. Secondary hypotheses are that RESTORE will lead to significant improvements in perceived health, quality of life, and functioning that will be maintained at one-month follow-up. Participants will be assessed at baseline, pre-intervention, during the intervention (after module 4), immediately after the intervention, and 1 month after completion of the intervention.

Enrollment

20 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Experienced a traumatic or extremely stressful experience related to being COVID-19+ or having a close other who was COVID-19+
  • Participants who were COVID+ will be eligible once they are no longer exhibiting COVID-19 symptoms and those who were hospitalized will be eligible post-discharge
  • Close others will be eligible once their close other with COVID-19 has recovered or if their loved one is deceased
  • ≥ 18 years of age
  • Scores at above clinical threshold on at least one of: Patient Health Questionnaire-9 ([PHQ-9] score ≥ 10), Generalized Anxiety Disorder Scale-7 ([GAD-7] score ≥ 10), and/or Posttraumatic Stress Disorder Scale-5 ([PCL-5] score ≥ 33)
  • Access to a computer or a tablet with high speed internet access, be able to clearly see the screen of a computer or tablet, and be fluent in English
  • Ability to provide consent

Exclusion criteria

  • Elevated risk of suicide
  • Currently enrolled in another intervention or treatment (e.g., cognitive behavioural therapy) for stress responses related to the COVID-19 pandemic

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

RESTORE intervention
Experimental group
Description:
Participants who screen eligible and consent will receive RESTORE with guidance.
Treatment:
Behavioral: RESTORE: Recovering from Extreme Stressors Through Online Resources and E-health

Trial contacts and locations

1

Loading...

Central trial contact

Candice Monson, PhD; Kathryn Trottier, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems